These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3267172)

  • 1. T-cell activation in health and disease.
    Feldmann M
    Immunol Today; 1988 May; 9(5):121-4. PubMed ID: 3267172
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell-helper factors in autoimmunity.
    Mozes E; Mendlovic S; Bentwich Z; Brautbar C; Shoenfeld Y
    Isr J Med Sci; 1988 Jul; 24(7):355-8. PubMed ID: 2457001
    [No Abstract]   [Full Text] [Related]  

  • 3. [HLA antigen genes and their clinical significance].
    Kikuchi I; Sasazuki T
    Rinsho Byori; 1985 Nov; 33 Spec No 65():160-73. PubMed ID: 3937922
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte subsets and surface molecules in man.
    Krensky AM; Lanier LL; Engleman EG
    Clin Immunol Rev; 1985; 4(1):95-138. PubMed ID: 2992859
    [No Abstract]   [Full Text] [Related]  

  • 5. Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.
    Gebel HM; Lebeck LL; Jensik SC; Landay AL; Bray RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1745-6. PubMed ID: 2523590
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of functional cell surface antigens in T cell activation.
    Bierer BE; Mentzer SJ; Greenstein JL; Burakoff SJ
    Year Immunol; 1986; 2():39-59. PubMed ID: 2953146
    [No Abstract]   [Full Text] [Related]  

  • 7. The T cell circuit: clinical and biological implications.
    Romain PL; Schlossman SF
    Adv Intern Med; 1986; 31():1-16. PubMed ID: 2868620
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative pathways for T lymphocyte activation.
    Shevach EM
    Prog Clin Biol Res; 1989; 288():127-40. PubMed ID: 2566174
    [No Abstract]   [Full Text] [Related]  

  • 9. RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating properties.
    Vaessen LM; Kreeftenberg JG; Heyse P; Leerling MF; Baumgartner D; Hendriks GF; Jutte NH; Weimer W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1026-7. PubMed ID: 2523112
    [No Abstract]   [Full Text] [Related]  

  • 10. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell activation by monoclonal antibodies: an approach to study principles of immunoregulation.
    Meuer SC; Schraven B; Möbius U
    Transplant Proc; 1988 Apr; 20(2):269-72. PubMed ID: 2834837
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of rat autoimmune disease by a monoclonal antibody specific for T lymphoblasts.
    Schluesener H; Brunner C; Vass K; Lassmann H
    J Immunol; 1986 Dec; 137(12):3814-20. PubMed ID: 3491149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
    De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
    J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential activation of CD45RA+ cells by a monoclonal antibody to the alpha/beta T-cell receptor.
    Schwinzer R; Schlitt HJ; Wonigeit K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):277-8. PubMed ID: 1824983
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor-like role of HLA-class I antigens: regulation of T cell activation.
    Dasgupta JD; Yunis EJ
    J Immunol; 1987 Aug; 139(3):672-7. PubMed ID: 3298432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Ghobrial I; Fuccello AJ; Stuart FP; Bluestone JA
    Transplant Proc; 1991 Feb; 23(1 Pt 1):81-2. PubMed ID: 1824999
    [No Abstract]   [Full Text] [Related]  

  • 20. [The T cell receptor abnormalities and autoimmune diseases].
    Takeno M; Sakane T
    Tanpakushitsu Kakusan Koso; 1990 Apr; 35(5):865-73. PubMed ID: 2362962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.